BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 593701)

  • 1. Long-term clinical trial with porcine monocomponent lente insulin (Monotard).
    Bruni B; Bruni Bocher K; Gamba S; Giolitti A; Rittatore R; Turco GL
    Panminerva Med; 1977; 19(4):247-54. PubMed ID: 593701
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical experiences with monocomponent insulins].
    Bruni Bocher K; Giolitti A; Turco GL; Benedetto P; Bruni B
    Minerva Med; 1975 Mar; 66(19):909-30. PubMed ID: 1124144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term clinical results with monocomponent insulin (MC lente) in infantile and juvenile diabetes].
    Bruni KB; Neirotti R; Albonico G; Gamba S; Regis G; D'Adda A; Soldano E; Bruni B
    Ann Osp Maria Vittoria Torino; 1976; 19(16):7-26. PubMed ID: 1027349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Proinsulin and a-component antibodies in diabetics treated with monocomponent and conventional insulin].
    Gamba S; Barbero PL; Bollati C; Castellazzi R; D'Adda A; Bruni B
    Minerva Dietol Gastroenterol; 1979; 25(3):309-14. PubMed ID: 400003
    [No Abstract]   [Full Text] [Related]  

  • 5. [The antigenicity of various new chromatographically purified depot insulin preparations].
    Graber D; Fankhauser S
    Schweiz Med Wochenschr; 1978 Nov; 108(46):1807-9. PubMed ID: 715418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in daily insulin requirement in diabetics switched to monocomponent insulin treatment].
    Bruni B; Turco GL
    Minerva Med; 1973 Nov; 64(80):4224-31. PubMed ID: 4765430
    [No Abstract]   [Full Text] [Related]  

  • 7. Proinsulin and A-component antibodies in diabetics after long-term monocomponent insulin treatment.
    Bruni B; Gamba S; Regis G; Turco GL
    Diabetologia; 1978 Mar; 14(3):165-9. PubMed ID: 566232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical observations on the action and dosage of insulin lente Polfa produced from porcine pancreas].
    Babiński S; Wesolowski J; Romanowska-Górecka B; Walecka E
    Wiad Lek; 1970 Apr; 23(8):681-7. PubMed ID: 5466041
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment with monocomponent semi-lente insulin in diabetes of difficult compensation].
    Barbero L; Gamba S; Zanno C; Regis G; Bruni B
    Minerva Med; 1978 Apr; 69(21):1437-42. PubMed ID: 683547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experiences in the treatment of diabetes with insulins of monocomponent (MC) and monospecies (MS) type].
    Andreani D; Iavicoli M; Colletti A; Menzinger G
    Folia Endocrinol; 1972 Dec; 25(6):516-39. PubMed ID: 4581824
    [No Abstract]   [Full Text] [Related]  

  • 11. [Monocomponent insulins (author's transl)].
    Rodriguez-Miñón JL
    MMW Munch Med Wochenschr; 1977 Sep; 119(38):1215-20. PubMed ID: 409943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behaviour of insulin antibodies in diabetics treated with different insulins.
    Mincu I; Cheţa D; Ionescu-Tîrgovişte C; Mirodon Z; Sîntu E
    Med Interne; 1980; 18(4):347-52. PubMed ID: 7006044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum levels of insulin-binding antibodies treated with monocomponent insulin].
    Czyzyk A; Lawecki J; Rogala H; Miedzińska E; Popik-Hankiewicz A
    Pol Tyg Lek; 1974 Feb; 29(8):301-4. PubMed ID: 4856084
    [No Abstract]   [Full Text] [Related]  

  • 14. [The study of insulin antibodies in different forms of diabetes mellitus].
    Mincu I; Ionescu-Tirgovişte C; Cheţa D; Simionescu L; Mirodon Z; Vasilescu V; Bruckner I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979; 31(5):421-8. PubMed ID: 44565
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes of insulin antibodies after monocomponent insulin therapy].
    Takemura Y; Kase T; Hiraiwa M; Hashigami Y; Imai N
    Horumon To Rinsho; 1982 Oct; 30(10):1109-12. PubMed ID: 7165985
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experiences with monocomponent insulin].
    Fagerberg SE; Gamstedt A
    Lakartidningen; 1976 Nov; 73(47):4097-9. PubMed ID: 994601
    [No Abstract]   [Full Text] [Related]  

  • 17. [Advances in insulin treatment. Evaluation of isophane or lente insulin, mixed with rapid insulin and injected twice-a-day].
    Cucinotta D; Lunetta M
    Minerva Endocrinol; 1990; 15(2):111-6. PubMed ID: 2098651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin antibodies in diabetics receiving a single type of insulin.
    Mincu I; Cheţa D
    Med Interne; 1982; 20(1):9-13. PubMed ID: 6765628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [KH metabolic pattern and insulin antibody level during treatment of diabetes mellitus with conventional and/or prepurified insulin preparations].
    Göbel P; Kramer W; Heni F
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1426-9. PubMed ID: 611859
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical trial with monocomponent lente insulins. Preliminary report.
    Bruni B; D'Alberto M; Osenda M; Ricci C; Turco GL
    Diabetologia; 1973 Dec; 9(6):492-8. PubMed ID: 4589824
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.